300858 科拓生物
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资25,23210.67%22,8002,3352,0182,016
投资性房地产0--0000
固定资产796,195114.44%371,284372,861207,055197,548
在建工程70,304-86.02%502,865172,069156,65238,739
无形资产58,784-2.19%60,10248,32651,05953,045
商誉1,9130.00%1,9131,9131,9131,913
其他非流动资产225,954173.53%82,606363,388435,853171,431
1,178,38213.14%1,041,571960,893854,550464,692

流动资产
货币资金326,417227.41%99,696108,635191,596875,358
应收账款73,3296.17%69,06556,47465,395103,266
存货53,32614.76%46,46646,59939,22350,933
其他流动资产396,724-47.94%762,111742,996659,337297,428
849,796-13.05%977,338954,705955,5511,326,986

流动负债
短期借款0--0000
应付票据0--0000
应付帐款126,18643.27%88,07647,72816,06136,448
其他流动负债60,77353.76%39,52448,46142,57748,833
186,96046.52%127,60096,18958,63885,281
流动资产净值662,836-22.00%849,738858,516896,9131,241,705
资产总额减流动负债1,841,218-2.65%1,891,3091,819,4091,751,4631,706,397

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债49,1961.47%48,48129,84118,4629,829
49,1961.47%48,48129,84118,4629,829

总权益
    实收股本263,4950.00%263,495263,495263,495175,663
    储备项目1,528,527-3.22%1,579,3331,526,0731,469,5061,520,905
股东权益1,792,022-2.76%1,842,8281,789,5681,733,0011,696,568
非控股权益0--0000